-
1
-
-
0016700157
-
The determination of fluoride ion concentration in biological fluids and the serum and urine of fluoride treated patients with Paget's disease and osteoporosis
-
1. Cowell, D. C. The determination of fluoride ion concentration in biological fluids and the serum and urine of fluoride treated patients with Paget's disease and osteoporosis. Med Lab Tech 32:73-89; 1975.
-
(1975)
Med Lab Tech
, vol.32
, pp. 73-89
-
-
Cowell, D.C.1
-
2
-
-
0017745528
-
Automated fluoride ion determination. Determination of serum fluoride ion levels
-
2. Cowell, D. C. Automated fluoride ion determination. Determination of serum fluoride ion levels. Ann Clin Biochern 14:269-274; 1977.
-
(1977)
Ann Clin Biochern
, vol.14
, pp. 269-274
-
-
Cowell, D.C.1
-
3
-
-
0017745529
-
Automated fluoride ion determination. Determination of serum fluoride ion levels
-
3. Cowell, D. C. Automated fluoride ion determination. Determination of serum fluoride ion levels. Ann Clin Biochem 14:275-278; 1977.
-
(1977)
Ann Clin Biochem
, vol.14
, pp. 275-278
-
-
Cowell, D.C.1
-
4
-
-
0025321429
-
The future of hip fractures in the United States: Numbers, costs and potential effects of postmenopausal estrogen
-
4. Cummings, S. R., Rubin, S. M., and Black, D. The future of hip fractures in the United States: Numbers, costs and potential effects of postmenopausal estrogen. Clin Orthopaed 252:163-166; 1990.
-
(1990)
Clin Orthopaed
, vol.252
, pp. 163-166
-
-
Cummings, S.R.1
Rubin, S.M.2
Black, D.3
-
5
-
-
0025179020
-
Treatment of vertebral osteoporosis with disodium monofluorophosphate: Comparison with sodium fluoride
-
5. Delmas, P. D., Dupuis, J., Duboef, F., Chapuy, M. C., and Meunier, P. J. Treatment of vertebral osteoporosis with disodium monofluorophosphate: Comparison with sodium fluoride. J Bone Miner Res 5:S143-S147; 1990.
-
(1990)
J Bone Miner Res
, vol.5
-
-
Delmas, P.D.1
Dupuis, J.2
Duboef, F.3
Chapuy, M.C.4
Meunier, P.J.5
-
6
-
-
0023125796
-
Fluoride therapy for osteoporosis: Characterisation of the skeletal response by serial measurements of serum alkaline phosphatase activity
-
6. Farley, A. M. G., Wergedal, J. E., Smith, L. C., Lundy, M. W., Farley, J. R., and Baylink, D. J. Fluoride therapy for osteoporosis: Characterisation of the skeletal response by serial measurements of serum alkaline phosphatase activity. Metabolism 36:211-218; 1987.
-
(1987)
Metabolism
, vol.36
, pp. 211-218
-
-
Farley, A.M.G.1
Wergedal, J.E.2
Smith, L.C.3
Lundy, M.W.4
Farley, J.R.5
Baylink, D.J.6
-
7
-
-
0026657108
-
Spinal fractures during fluoride therapy for osteoporosis: Relationship to spinal bone density
-
7. Farley, S. M., Wergedal, J. E., Farley, J. R., Javier, G. N., et al. Spinal fractures during fluoride therapy for osteoporosis: Relationship to spinal bone density. Osteopor Int 2:213-218; 1992.
-
(1992)
Osteopor Int
, vol.2
, pp. 213-218
-
-
Farley, S.M.1
Wergedal, J.E.2
Farley, J.R.3
Javier, G.N.4
-
8
-
-
0020620618
-
Bilateral fractures of femoral neck in patients with mild to moderate renal failure receiving fluoride for spinal osteoporosis
-
8. Gerster, J. C., Charhon, S. A., Jaeger, P. J., Boivin, G., Briancon, D., Rostan, A., Baud, C. A., and Meunier, P. J. Bilateral fractures of femoral neck in patients with mild to moderate renal failure receiving fluoride for spinal osteoporosis. Br Med J 287:723-725; 1983.
-
(1983)
Br Med J
, vol.287
, pp. 723-725
-
-
Gerster, J.C.1
Charhon, S.A.2
Jaeger, P.J.3
Boivin, G.4
Briancon, D.5
Rostan, A.6
Baud, C.A.7
Meunier, P.J.8
-
9
-
-
0025031696
-
Spontaneous hip fractures in fluoride-treated patients: Potential causative factors
-
9. Gutterridge, D. H., Price, R. I., Kent, G. N., Prince, R. L., and Mitchell, P. A. Spontaneous hip fractures in fluoride-treated patients: Potential causative factors. J Bone Miner Res 5(Suppl. 1):S205-215; 1990.
-
(1990)
J Bone Miner Res
, vol.5
, Issue.SUPPL. 1
-
-
Gutterridge, D.H.1
Price, R.I.2
Kent, G.N.3
Prince, R.L.4
Mitchell, P.A.5
-
10
-
-
0024416673
-
The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride
-
10. Hodsman, A. B. and Drost, D. J. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride. J Clin Endocrinol Metabol 69:932-938; 1989.
-
(1989)
J Clin Endocrinol Metabol
, vol.69
, pp. 932-938
-
-
Hodsman, A.B.1
Drost, D.J.2
-
11
-
-
0025358094
-
Effect of fluoride on postmenopausal osteoporosis
-
11. Kanis, J. A. Effect of fluoride on postmenopausal osteoporosis. N Engl J Med 323:416; 1990.
-
(1990)
N Engl J Med
, vol.323
, pp. 416
-
-
Kanis, J.A.1
-
12
-
-
0027373495
-
Treatment of symptomatic osteoporosis with fluoride
-
12. Kanis, J. A. Treatment of symptomatic osteoporosis with fluoride. Am J Med 95(Suppl. 5A):S53-S61; 1993.
-
(1993)
Am J Med
, vol.95
, Issue.SUPPL. 5A
-
-
Kanis, J.A.1
-
13
-
-
0027245693
-
Sodium fluoride therapy of postmenopausal osteoporosis
-
13. Kleerekoper, M. and Mendlovic, D. B. Sodium fluoride therapy of postmenopausal osteoporosis. Endocrine Rev 14:328-339; 1993.
-
(1993)
Endocrine Rev
, vol.14
, pp. 328-339
-
-
Kleerekoper, M.1
Mendlovic, D.B.2
-
14
-
-
0026166893
-
A randomised trial of sodium fluoride as a treatment for postmenopausal ostoeporosis
-
14. Kleerekoper, M., Peterson, E. L., Nelson, D. A., et al. A randomised trial of sodium fluoride as a treatment for postmenopausal ostoeporosis. Osteopor Int 1:155-161; 1991.
-
(1991)
Osteopor Int
, vol.1
, pp. 155-161
-
-
Kleerekoper, M.1
Peterson, E.L.2
Nelson, D.A.3
-
15
-
-
0025072130
-
Fluoride pharmacokinetics in good and poor responders to fluoride therapy
-
15. Kraenzlin, M. E., Kraenzlin, C., Farley, S. M. G., Fitzsimmons, R. J., and Baylink, D. J. Fluoride pharmacokinetics in good and poor responders to fluoride therapy. J Bone Miner Res 5:S49-S52; 1990.
-
(1990)
J Bone Miner Res
, vol.5
-
-
Kraenzlin, M.E.1
Kraenzlin, C.2
Farley, S.M.G.3
Fitzsimmons, R.J.4
Baylink, D.J.5
-
16
-
-
0025344927
-
Fluoride and bone-quantity versus quality
-
16. Lindsay, R. Fluoride and bone-quantity versus quality. New Engl J Med 322:845-846; 1990.
-
(1990)
New Engl J Med
, vol.322
, pp. 845-846
-
-
Lindsay, R.1
-
17
-
-
0023809288
-
Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis
-
17. Mamelle, N., Meunier, P. J., Dusan, R., Guillaume, M., Martin, J. L., Gaucher, A., Prost, A., Zeigler, G., and Netter, P. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet ii:361-365; 1988.
-
(1988)
Lancet
, vol.2
, pp. 361-365
-
-
Mamelle, N.1
Meunier, P.J.2
Dusan, R.3
Guillaume, M.4
Martin, J.L.5
Gaucher, A.6
Prost, A.7
Zeigler, G.8
Netter, P.9
-
18
-
-
0027456454
-
Fluoride salts for vertebral osteoporosis: The benefit-to-risk ratio depends on the cumulative dose reaching bone
-
18. Meunier, P. J. and Boivin, G. Fluoride salts for vertebral osteoporosis: The benefit-to-risk ratio depends on the cumulative dose reaching bone. Osteopor Int S1:S211-214; 1993.
-
(1993)
Osteopor Int
, vol.S1
-
-
Meunier, P.J.1
Boivin, G.2
-
19
-
-
0025148128
-
Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements
-
19. Nagant de Deuxchaisnes, C., Devogelaer, J.-P., Depresseux, G., Malghem, J., and Maldague, B. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements. J Bone Miner Res 5:S5-S26; 1990.
-
(1990)
J Bone Miner Res
, vol.5
-
-
Nagant De Deuxchaisnes, C.1
Devogelaer, J.-P.2
Depresseux, G.3
Malghem, J.4
Maldague, B.5
-
20
-
-
0029090252
-
Treatment of postmenopausal osteoporosis with slow-release fluoride
-
20. Pak, C. Y. C., Sakhaee, K., Adams-Huet, B., Piziak, V., Peterson, R. D., and Pointdexter, J. R. Treatment of postmenopausal osteoporosis with slow-release fluoride. Ann Intern Med 123:401-409; 1995.
-
(1995)
Ann Intern Med
, vol.123
, pp. 401-409
-
-
Pak, C.Y.C.1
Sakhaee, K.2
Adams-Huet, B.3
Piziak, V.4
Peterson, R.D.5
Pointdexter, J.R.6
-
21
-
-
0025726195
-
Fluoride treatment in osteoporosis
-
21. Pitt, P. and Berry, H. Fluoride treatment in osteoporosis. Postgrad Med J 67:323-326; 1991.
-
(1991)
Postgrad Med J
, vol.67
, pp. 323-326
-
-
Pitt, P.1
Berry, H.2
-
22
-
-
0026102826
-
Fluoride therapy in postmenopausal osteopenic women: Effect on vertebral and femoral bone density and
-
22. Pouilles, J. M., Tremollieres, F., Causse, E., Louvet, J. P., and Ribot, C. Fluoride therapy in postmenopausal osteopenic women: Effect on vertebral and femoral bone density and prediction of bone response. Osteopor Int 1:103-109; 1991.
-
(1991)
Osteopor Int
, vol.1
, pp. 103-109
-
-
Pouilles, J.M.1
Tremollieres, F.2
Causse, E.3
Louvet, J.P.4
Ribot, C.5
Response, P.O.B.6
-
23
-
-
0022625922
-
Involutional osteoporosis
-
23. Riggs, B. L. and Melton, L. J. III. Involutional osteoporosis. N Engl J Med 314:1676-1686; 1986.
-
(1986)
N Engl J Med
, vol.314
, pp. 1676-1686
-
-
Riggs, B.L.1
Melton L.J. III2
-
24
-
-
0026732689
-
The prevention and treatment of osteoporosis
-
24. Riggs, B. L. and Melton, L. J. The prevention and treatment of osteoporosis. N Engl J Med 327:620-627; 1992.
-
(1992)
N Engl J Med
, vol.327
, pp. 620-627
-
-
Riggs, B.L.1
Melton, L.J.2
-
25
-
-
0025374223
-
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteporosis
-
25. Riggs, B. L., Hodgson, S. F., O'Fallon, W. M., Chao, E. Y. S., Wahner, H. W., Muhs, J. M., Cedel, S. L., and Melton, L. J. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteporosis. N Engl J Med 322:802-809; 1990.
-
(1990)
N Engl J Med
, vol.322
, pp. 802-809
-
-
Riggs, B.L.1
Hodgson, S.F.2
O'Fallon, W.M.3
Chao, E.Y.S.4
Wahner, H.W.5
Muhs, J.M.6
Cedel, S.L.7
Melton, L.J.8
-
26
-
-
0028006249
-
Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis
-
26. Riggs, B. L., O'Fallon, W. M., Lane, A., et al. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis. J Bone Miner Res 9:265-275; 1994.
-
(1994)
J Bone Miner Res
, vol.9
, pp. 265-275
-
-
Riggs, B.L.1
O'Fallon, W.M.2
Lane, A.3
-
27
-
-
0023318391
-
Incidence of hip fractures in osteoporotic women treated with sodium fluoride
-
27. Riggs, B. L., Baylink, D. J., Kleerekoper, M., Lane, J. M., Melton, L. J., and Meunier, P. J. Incidence of hip fractures in osteoporotic women treated with sodium fluoride. J Bone Miner Res 2:123-126; 1987.
-
(1987)
J Bone Miner Res
, vol.2
, pp. 123-126
-
-
Riggs, B.L.1
Baylink, D.J.2
Kleerekoper, M.3
Lane, J.M.4
Melton, L.J.5
Meunier, P.J.6
-
28
-
-
0028953219
-
What is the future for fluoride in the treatment of osteoporosis?
-
28. Ringe, J. D. and Meunier, P. J. What is the future for fluoride in the treatment of osteoporosis? Osteopor Int 5:71-74; 1995.
-
(1995)
Osteopor Int
, vol.5
, pp. 71-74
-
-
Ringe, J.D.1
Meunier, P.J.2
-
29
-
-
0025427001
-
Sodium fluoride: Too late and too toxic for the elderly osteoporotic patient?
-
29. Seymour, D. G., Day, J. J., and Pathy, M. S. J. Sodium fluoride: Too late and too toxic for the elderly osteoporotic patient? Age Ageing 19:222-228; 1990.
-
(1990)
Age Ageing
, vol.19
, pp. 222-228
-
-
Seymour, D.G.1
Day, J.J.2
Pathy, M.S.J.3
-
30
-
-
0014785497
-
New approaches to the treatment of bone disease with fluoride
-
30. Taves, D. R. New approaches to the treatment of bone disease with fluoride. Fed Proc 29:1185-1187; 1970.
-
(1970)
Fed Proc
, vol.29
, pp. 1185-1187
-
-
Taves, D.R.1
|